ClinicalTrials.Veeva

Menu

Deep Brain Stimulation (DBS) Frequency Effects on Gait in Parkinson's Disease(PD)

Vanderbilt University logo

Vanderbilt University

Status and phase

Completed
Phase 2
Phase 1

Conditions

Parkinson Disease

Treatments

Procedure: Frequency change to 130 Hz
Procedure: Frequency change to 60 Hz

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

In this study the investigators will evaluate the effect of both low and high frequency Deep Brain stimulation of the subthalamic nucleus (STN) in Parkinson's patients who have noted a change in their walking. The investigators' hypothesis is:

  1. Stimulation at 60 Hertz (Hz) is associated with improved gait with increased stride length and faster time on the Stand walk sit test.
  2. There is no worsening of the Unified Parkinson's Disease Rating Scale (UPDRS) at 60 Hz.

Enrollment

20 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be a patient at the Vanderbilt Movement Disorders clinic.
  • Report a change in their gait.
  • Be able to walk independently when off PD medications for 12-16 hours.
  • Have a stable dose of PD medications for the prior three months .
  • Not cognitively impaired, so as to give informed consent.
  • MMSE > 24.

Exclusion criteria

  • See inclusion criteria.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Double Blind

20 participants in 1 patient group

Baseline frequency
No Intervention group
Description:
Baseline DBS frequency
Treatment:
Procedure: Frequency change to 60 Hz
Procedure: Frequency change to 130 Hz

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems